Biggest S&P 500 Movers on Monday

Advancers

• Shares of Mosaic (MOS) jumped 8%, the most of any S&P 500 stock, as the fertilizer maker announced an agreement to sell its Patos de Minas phosphate mine in Brazil to a local operator.
• It was also a positive day for shares of fellow agricultural nutrients manufacturer CF Industries (CF), as investment bank Piper Sandler upgraded the stock to "overweight" from "underweight." CF stock rose 7.6% as analysts predicted that reduced grain production in the U.S. and an improving outlook for grain prices would help underpin strong pricing in the company's key nitrogen fertilizer market.
• Diagnostics and life sciences firm Revvity (RVTY) said it had received regulatory approval for its automated test for measuring free testosterone levels. The company also announced a neonatal sequencing research partnership with Element Biosciences. Revvity shares gained 7.8%.
• Shares of healthcare companies with exposure to managed care plans moved higher Monday following last week's proposal by the U.S. government to boost 澳洲幸运5官方开奖结果体彩网:Medicare Advantage reimbursement rates by more than 4% in 2026. Shares of CVS Health (CVS) jumped 7.3%, while Humana (HUM) shares were up 6.8%.

Decliners

• Biotech and pharma giant Moderna (MRNA) 澳洲幸运5官方开奖结果体彩网:slashed its 2025 sales guidance by $1 billion, noting it expects revenue to be weighted toward the second half of the year and to be generated primarily by its COVID-19 and respiratory syncytial virus vaccines. Although Moderna also announced plans to cut costs by $1 billion this year and another $500 million in 2026, its shares plunged 16.8%, the steepest loss in the S&P 500.
• As tragic wildfires devastate Southern California, shares of area electric utility Edison International (EIX) extended the heavy declines posted last week, dropping 11.9% on Monday. Fire agencies are reportedly investigating whether electrical equipment from subsidiary Southern California Edison's could have played a role in igniting the Hurst Fire.
• Constellation Energy (CEG) shares sank 8.5%, reversing some of Friday's 澳洲幸运5官方开奖结果体彩网:surge of more than 25% posted by the stock after the energy producer announced an agreement to acquire rival Calpine. The $26.6 billion deal expands Constellation's footprint in California and Texas, and the company said the combination will create the 澳洲幸运5官方开奖结果体彩网:largest clean energy provider in the U.S.

-澳洲幸运5官方开奖结果体彩网:Michael Bromberg

TSMC Price Levels To Watch Ahead of Q4 Earnings

Taiwan Semiconductor Manufacturing Co. (TSM) shares will likely remain in the spotlight ahead of the contract chipmaker’s fourth-quarter earnings report due Thursday before the opening bell, with investors expecting 澳洲幸运5官方开奖结果体彩网:artificial intelligence (AI)-driven demand to fuel results.

Analysts expect the Taiwanese chip giant to post a quarterly profit of $11.4 billion, boosted by surging demand for advanced silicon used in AI infrastructure, Reuters reported. Investors will likely have high expectations after the company reported a 澳洲幸运5官方开奖结果体彩网:34% jump in 2024 sales.

The chipmaker’s outlook and 澳洲幸运5官方开奖结果体彩网:capital expenditure (CapEx) will likely come under close scrutiny as the company continues to spend billions on new factories amid the potential for export curbs and tariffs under the incoming Trump administration.

TSMC stock gained 80% in 2024 and was up 5% this year before falling Monday amid a broader 澳洲幸运5官方开奖结果体彩网:decline in chip stocks.

For a breakdown of technicals and important price levels to watch ahead of TSMC's earnings report, see here.

-澳洲幸运5官方开奖结果体彩网:Timothy Smith

Meta's Mark Zuckerberg Throws Cold Water on the Quantum Computing Rally

Shares of quantum computing companies continued to slide Monday after Meta CEO Mark 🌌Zuckerberg warned applications of the technology could be years away.

In an appearance on "The Joe Rogan Experience" podcast, published Friday, Zuckerberg said he believes quantum computing is "still quite a ways off from being a very useful paradigm."

Zuckerberg's appearance followed Nvidia (NVDA) CEO 澳洲幸运5官方开奖结果体彩网:Jensen Huang's assertion last week that "ver𝔉y useful quantum computers" are still 15 to 30 years away.

Rigetti Computing (RGTI) shares plunged more than 30% on Monday, after tumbling more than 50% last week. At the start of the year, the stock had soared more than 1,800% over the prior 12 months, boosted by 澳洲幸运5官方开奖结果体彩网:Google's unveiling of a "breaܫkthrough" qဣuantum computing chip in December.

D-Wave Quantum (QBTS) shares were down 33% late in Monday's session, while IonQ (IONQ) fell 14% and Quantum Computing (QUBT) dropped 27%.

-澳洲幸运5官方开奖结果体彩网:Andrew Kessel

Oi👍l Climbs to 5-Month High, Weighing on Travꦛel Stocks

Oil prices rose to a 5-month high on Monday, weighing on the stocks of airlines, cruise operators, and other companies whos𝔉e finances are directly affected by the price of fuel.

Brent crude, the global benchmark, rose more than 1% to about $81 a bar🌄rel, their highest level since August. West Texas Intermediate, the American benchmark, traded at $78.75 a barrel on Monday🍸 afternoon, a 3% increase from Friday.

Oil prices 澳洲幸运5官方开奖结果体彩网:jumped more than 3% at the end of last week after the Treasury Department announced sweeping sanctions against the Russian oil industry, raising concerns about possible disruptions to glob🦹al supply. 

Airlines, for which fuel is a large expense, were feeling the pressure on Monday. Shares of Delta Air Lines (DAL) and United Airlines (UAL) were each down nearly 4%. American Airlines (AAL) slumped more than 5%. Cruise operators like Carnival Corporation (CCL) and Norwegian Cruise Line Holdings (NCLH) ✃were also lower, dow🧸n about 2% and 1.5%, respectively. 

On the flip side, oil and natural gas producers were among the S&P 500's best performers on Monday. Shares of Baker Hughes (BKR) were up nearly 4% and oil major ExxonMobil (XOM) advanced nearly 3%.

Travel stocks finished the year strong as oil prices trended lower and consumers showed few signs that higher prices have dented robust post-pandemic travel demand. United Airlines was one of the S&P 500’s best-performing stocks in 2024. Its shares have more than doubled in value in the past year. Delta has gained about 67% over the same period. Royal Caribbean (RCL) stock was down slightly Monday, but has still risen more than 85% 🧜in the last 12 ꦑmonths.

Abercrombie & Fitch Lifꩵts Its Outlook—And Its Stocಞk Drops

Apparel retaile💦r Abercrombie & Fitch lifted its end-of-year outlook today. Its shares are falling anyway. 

Some of that might be attributable to an 澳洲幸运5官方开奖结果体彩网:iffy day for stocks, with the S&P 500 recently down about 0.1%. But the scale of Abercrombie’s (ANF) move—the shares were recently down about 19% to roughly $130, undoing some recent upward momen𒀰tum that started around mid-December—suggests more serious investor disappointment.

he details: Abercrombie told investors to expect fourth-quarter net sales growth of 7% to 8%, up from an earlier estimate of 5% to 7%. (I💦t also lifted its guidance for quarterly operating margins, amon🔥g other things.)

It may be that investors expected a bigger upside surprise or a longer-term update. Based on Visible Alpha data, analysts were looking for quarterly revenue growth of about 7%. The pre-announcement came ahead of a planned appearance by management at an investo🔯r conference Monday.

Some on Wall Street figured the lo♐ng-term story is still good. Analysts are broadly bullish on the shares, which have climbed over the past 12 months, and Jeffries—which has a “buy” rating and a $220 price target on ꦓthe stock, the latter of which is substantially higher than Visible Alpha’s consensus—called today’s drop an “opportunity.”

-澳洲幸运5官方开奖结果体彩网:David Marino-Nachison

Constellation Energy Price Levels To 🌺Watch as Stock Retr♎eats From Record High

Constellation Energy (CEG) shares retreated Monday after surging more than 25% Friday when the energy giant announced that it will 澳洲幸运5官方开奖结果体彩网:acquire rival Calpine in a deal valued at $26.6 billion.

Constellation Energy shares broke out from a 澳洲幸运5官方开奖结果体彩网:falling wedge pattern earlier this month, briefly retraced to the pattern's upper trendline, and then staged a 澳洲幸运5官方开奖结果体彩网:breakaway gap to a new all-time high (ATH) on Friday.

Importantly, Friday’s surge occurred on the third-highest day of澳洲幸运5官方开奖结果体彩网: trading volume since the energy giant went public in early 2022, signaling buying conviction from larger market participants, such as 澳洲幸运5官方开奖结果体彩网:institutional investors and hedge funds. 

The 澳洲幸运5官方开奖结果体彩网:relative strength index (RSI) confirms bullish price momentum with a reading above 70, but also indicates overbought conditions, opening the door to short-term profit-taking.🥃

During retracements, like the one seen Monday, investors should initially monitor the $280 level. The shares may find support in this area near a trendline that links the mid-October 澳洲幸运5官方开奖结果体彩网:countertrend peak with the low of Fridꦏay’s breakawayꦗ gap.

Finally, the bulls’ inability to defend this price could see a pullback to around the $236 level. Investors may look for buying opportunities in this region that finds a confluence of support from the prominent May 澳洲幸运5官方开奖结果体彩网:swing high, the 澳洲幸运5官方开奖结果体彩网:50-day moving average, and the falling wedge pattern’s ▨upper trendline.

Constellation shares were nearly 6% at $387.20 Moꦺnd🥂ay afternoon.

-澳洲幸运5官方开奖结果体彩网:Timothy Smith

Moderna Stock Plummets 20% After S𓆏lashing Rev💛enue Forecast

Shares of pharmaceutical giant Moderna (MRNA) plunged Monday after the company cut its 2025 revenue forecast by $1 billion.

The company now projects revenue of $1.5 billion to $2.5 billion this year, down from a prior estimate of $2.5 billion to $3.5 billion in September. That revenue is expected “mostly in the second half of💯 the year” in large part from sales of its Covid-19 and respiratory syncytial virus vaccines. Moderna also said it expects to cut $1 billion worth of expenses this year, with another $500 million reduction planned in 2026. 

Shares of Moderna dropped more than 20% intraday to $33.44, more than erasing gains last week after the first 澳洲幸运5官方开奖结果体彩网:bird-flu death was reported in the U.S. The stock has lost about two-thirds of its value over the past year and is well off its all-time high nea🐽r $49🍰0 in August 2021, during the COVID-19 pandemic.

-澳洲幸运5官方开奖结果体彩网:Andrew Kessel

U.S. Steel Stock Jumps as US Ex♚tends Deadline ♐To Axe Takeover

U.S. Steel (X) shares jumped Monday after the U.S. government extended the deadline for Nippon Steel to abandon its planned $14.1 billion acquisition of the American sꦐteelmaker to June.

U.S. Steel and Nippon Steel said in a statement that the Committee on Foreign Inve▨stm🍸ent in the United States—an inter-agency committee that assesses financial transactions—extended the deadline, which was originally in 🙈Februarꦓy.

Earlier this month, President Joe Biden blocked the sale of the icon😼ic American company to the Japanese firm on national security grounds.

“We are pleased that CFIUS 📖has granted an extension to June 18, 2025 of the requirement in President Biden’s Executive Order that the parties permanently abandon the transaction,” a joint statement by U.S. Steel and Nippon Steel said over the weekend. “We look forward to completing the transaction, which secures the best future for the American steel industry and all our stakeholders.”

The two companies last week sued the U.S. government over Biden’s blocking of the deal. Their suit, filed in the U.S😼.𒈔 Court of Appeals for the District of Columbia Circuit, alleges that Biden's order violated the “constitutional guarantee of due process and statutory procedural requirements,” and exerted “unlawful political influence."

U.S. Steel shares were up 8% late Monday morning, and have g🔴ained nearly 10% so far this year.

-澳洲幸运5官方开奖结果体彩网:Nisha Gopalan

Intra-Cellular Therapies Stock J♏umps on Johnson & Jꩵohnson Acquisition

Shares of Intra-Cellular Therapies (ITCI) surged about 35% Monday morning after Johnson & Johnson (JNJ) said it would acquire the biopharmaceutical company for roughly $14.6 billion.

Johnson & Johnson will pay Intra-Cellular shareholders $132 per share, a premium of roughly 40% to the latter's close at the end of last week. Shares jumped 15% to a record closing high of $94.87 Friday after the company announced it had settled a patent lawsuit with Sandoz, which was looking to produce and sell a generic version of Intra-Cellular's Caplyta, which treats schizophrenia and bipolar I and II depression.

The company is also developing drugs to treat Alzheimer's Disease and Parkinson's Disease, among others.

"This acquisition further differentiates our portfolio, serves as a strategic near- and long-term growth catalyst for Johnson & Johnson and offers compelling value to patients, health systems and shareholders," Johnson & Johnson CEO Joaquin Duato said.

The companies said the deal is expected ꦆto close later this year pending approval from regulators and Intra-Cellular shareholders, with Johnson & Johnson funding the deal through a combination of cash and debt.

Intra-Cellular shares rose to a🐻 record $127.70 Monday morning, while Johnson & Johnson shares were up about 1%.

-澳洲幸运5官方开奖结果体彩网:Aaron McDade

Apple Stoܫck Slip💫s as iPhone Reportedly Concedes Market Share

Apple's (AAPL) global smartphone market share slipped one percentage point to 18% last year as fourth-quarter iPhone sales dropped 5%, according to Counterpoint Research.

Bloomberg earlier had reported the fourth-quarter slump, reflecting the U.S. firm's lack of 澳洲幸运5官方开奖结果体彩网:artificial intelligence (AI) features in its phones in China, and a spokesperson at the research firm confirmed the figure.

Apple's global smartphone sales dropped 2% year-over-year at a time when the overall market grew 4%, as the iPhone 16 series "was met with a mixed response, partly due to a lack of availability of Apple Intelligence at launch," Counterpoint said.

Still, Counterpoint analyst Ivan Lam said that Apple's premium products are winning fans.

"iPhone sell-through was down, but consumers are pivoting to Apple's ultra-high end, helping to offset some of the declines," Lam said. "In markets like China, we're seeing sell-through share of Pro series devices ballooning."

Shares of Apple were down more than 2% early Monday morning, bringing their year🍒-to-date decline to nearly 8%.

-澳洲幸运5官方开奖结果体彩网:Nisha Gopalan

Stock Futures Slump as Rate Cut Hopes Fade

Futures contracts connected to the Dow ♚Jones Industrial Average were slightly lower in premarket trading on Monday.

S&P 500 futures were down 0.6%.

Nasdaq 100 futures declined 0.9%.